P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12 - Archive ouverte HAL Access content directly
Conference Papers Retrovirology Year : 2009

P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12

(1) , (1) , (2) , (1)
1
2

Abstract

n.a

Domains

Life Sciences [q-bio] Human health and pathology Infectious diseases
Fichier principal
Vignette du fichier
1742-4690-6-S3-P45.pdf (136.96 Ko) Télécharger le fichier
Vignette du fichier
1742-4690-6-S3-P45.xml (5.05 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Ed. BMC  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00663918

Submitted on : Friday, January 27, 2012-5:19:57 PM

Last modification on : Tuesday, January 11, 2022-5:56:05 PM

Long-term archiving on: Saturday, April 28, 2012-2:42:16 AM

Download

Dates and versions

inserm-00663918 , version 1 (27-01-2012)

Identifiers

Cite

Antoine Chaillon, Martine Braibant, Brigitte Autran, Francis Barin. P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12. AIDS Vaccine 2009, Oct 2009, Paris, France. pp.P45, ⟨10.1186/1742-4690-6-S3-P45⟩. ⟨inserm-00663918⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UPMC UNIV-TOURS SORBONNE-UNIVERSITE
70 View
100 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More